These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 12410546

  • 1. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.
    Andreatini R, Sartori VA, Seabra ML, Leite JR.
    Phytother Res; 2002 Nov; 16(7):650-4. PubMed ID: 12410546
    [Abstract] [Full Text] [Related]

  • 2. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 3. Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
    De Candia MP, Di Sciascio G, Durbano F, Mencacci C, Rubiera M, Aguglia E, Garavini A, Bersani G, Di Sotto A, Placidi G, Cesana BM.
    Clin Ther; 2009 Dec; 31(12):2851-9. PubMed ID: 20110024
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J.
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [Abstract] [Full Text] [Related]

  • 5. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M, Klimm HD.
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [Abstract] [Full Text] [Related]

  • 6. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH, Tiller J, Xie F, Trivedi MH.
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [Abstract] [Full Text] [Related]

  • 7. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 8. Valerian for anxiety disorders.
    Miyasaka LS, Atallah AN, Soares BG.
    Cochrane Database Syst Rev; 2006 Oct 18; (4):CD004515. PubMed ID: 17054208
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST, Park JH, Kim M.
    Headache; 2005 Sep 18; 45(8):1004-11. PubMed ID: 16109114
    [Abstract] [Full Text] [Related]

  • 10. The special extract ERr 731 of the roots of Rheum rhaponticum decreases anxiety and improves health state and general well-being in perimenopausal women.
    Kaszkin-Bettag M, Ventskovskiy BM, Kravchenko A, Rettenberger R, Richardson A, Heger PW, Heger M.
    Menopause; 2007 Sep 18; 14(2):270-83. PubMed ID: 17213754
    [Abstract] [Full Text] [Related]

  • 11. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP, Kieser M.
    Pharmacopsychiatry; 1997 Jan 18; 30(1):1-5. PubMed ID: 9065962
    [Abstract] [Full Text] [Related]

  • 12. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R, Annable L, Chouinard G, Ogilvie RI.
    J Clin Psychopharmacol; 1983 Apr 18; 3(2):80-7. PubMed ID: 6132936
    [Abstract] [Full Text] [Related]

  • 13. Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
    Bassi S, Albizzati MG, Ferrarese C, Frattola L, Cesana B, Piolti R, Farolfi A.
    Clin Neuropharmacol; 1989 Feb 18; 12(1):67-74. PubMed ID: 2565767
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 18; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan.
    Inada T, Nozaki S, Inagaki A, Furukawa TA.
    Hum Psychopharmacol; 2003 Aug 18; 18(6):483-7. PubMed ID: 12923829
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder.
    Koetter U, Schrader E, Käufeler R, Brattström A.
    Phytother Res; 2007 Sep 18; 21(9):847-51. PubMed ID: 17486686
    [Abstract] [Full Text] [Related]

  • 17. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.
    Garrison R, Chambliss WG.
    Altern Ther Health Med; 2006 Sep 18; 12(1):50-4. PubMed ID: 16454147
    [Abstract] [Full Text] [Related]

  • 18. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R, Lamontagne Y.
    J Clin Psychopharmacol; 1984 Jun 18; 4(3):125-9. PubMed ID: 6145726
    [Abstract] [Full Text] [Related]

  • 19. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA, Vermani M, Jacobs L, Marcus M, Kong B, Lessard S, Galarraga W, Struzik L, Gendron A.
    J Anxiety Disord; 2008 Dec 18; 22(8):1480-6. PubMed ID: 18455360
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.
    Bipolar Disord; 2009 Aug 18; 11(5):483-93. PubMed ID: 19624387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.